Intermountain Healthcare taps diversity leader to be new chief equity officer

Tiffany Capeles has been named chief equity officer for Intermountain Healthcare––the first such role for the Salt Lake City-based health system.

Capeles is a nationally recognized diversity leader, most recently serving as director of health equity, diversity, and inclusion at Christus Health, an international health system based in Texas. During her tenure at Christus, the organization received numerous national awards, designations, and recognition in the areas of health equity, diversity and inclusion, according to a press release from Intermountain.

Health Exec Summary

Chief equity officer is a rising role across industries. Healthcare organizations and companies have increasingly focused on adding equity to their c-suite over the past few years. The American Medical Association hired Aletha Maybank, MD, MPH, as its first-ever chief health equity officer in 2019, while Brigham and Women’s Hospital, Mass General Brigham, CVS Health, University of Illinois Hospital and Health System, Partners Healthcare and many more have named executives for similar roles in the past few years, some for the very first time.

Capeles has also received honors, including a career achievement award from National Association of Latino Healthcare Executives last year. In 2020, she was named as one of the Top 25 emerging leaders by Modern Healthcare, and she received the 2019 Tomorrow’s Leaders Award by the Catholic Healthcare Association. Prior to her time at Christus, she served in multiple roles at Children’s Health in Texas and Adventist HealthCare in Maryland.

”Tiffany’s informed approach and experience align well with our four pillars as we advance equity for our patients, members, caregivers, and communities,” Mikelle Moore, Intermountain senior vice president and chief community health officer, said in the press release. “She will provide visionary leadership that will continue our focus on equity as a social determinant of health to help people live the healthiest lives possible.” 

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.